from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1961/-

LFCtreatmentdescriptionclass of inhibitor

0.542

Amikacinug/mL Amikacintranslation

-0.116

Cap5-10ug/mL Capreomycintranslation

-0.081

Rox10-50 ug/mL Roxithromycintranslation

0.289

SM2-5 ug/mL Streptomycintranslation

0.562

Tet5-10 ug/mL Tetracyclinetranslation

0.426

Rif0.2-5ug/mL Rifampicintranscription

0.006

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.089

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.354

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.072

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.297

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.336

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.053

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.437

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.163

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.164

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.058

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.155

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.033

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.406

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.595

Nigericin50 uM Nigericinrespiration

-0.224

TRC10-150 ug/mL Triclosanrespiration

0.141

TRZ10-25 ug/mL Thioridazinerespiration

3.576

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.937

menadione6-10 ug/mL Menadionerespiration

-0.113

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.081

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.105

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.698

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.667

NRP_1Non-replicating persistence stage 1dosRassociated

-0.796

Amp0.2mg/mL AmpicillincellWall

-0.218

Cephalexin20-100 ug/mL CephalexincellWall

0.168

Cerulenin0.32-5 ug/mL CerulenincellWall

0.200

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.153

EMB10-20 ug/mL EthambutolcellWall

-0.179

Eta12-40 ug/mL EthionamidecellWall

-0.661

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.170

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.381

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.032

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.221

BZA0.12 mg/mL BenzamidearomaticAmides

0.441

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.099

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.630

H2O24 mM hydrogen peroxideDNAdamaging

-0.367

Levo10 ug/mL LevofloxacinDNAdamaging

0.500

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.087

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.139

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.576

UVUV-irradiationDNAdamaging

-0.945

ARP41-4 ug/mL Antitubercular compound ARP4?

0.107

Antimycin12.5-50 ug/mL Antimycin A?

-1.516

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.053

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.205

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.060

PA8240.2-2 ug/mL PA-824?

-0.339

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.275

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.378

Verapamil50 uM Verapamil?

-0.950

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.681

methoxatin10-20 ug/mL Methoxatin?